涅拉提尼布衍生物7A通过p53通路诱导结肠癌细胞的亡
Zhi-Yu Liu1, Ruo-Tong Liu1, Wen-Hao Cheng1
1College of Pharmacy, Jiangsu Ocean University, Lianyungang 222000, China.
一种内拉丁尼布衍生物,7A,通过诱导DNA损伤和亡,对结直肠癌治疗有希望. 这种化合物还减少了瘤生长和血管生成,突出了其治疗潜力.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 分子生物学分子生物学
背景情况:
- 结肠直肠癌 (CRC) 的发病率正在上升,需要新的治疗策略.
- 涅拉提尼布衍生物7A先前表现出抗瘤活性,但其CRC特异性机制尚不清楚.
研究的目的:
- 在结直肠癌中全面研究内拉提尼布衍生物7A的作用机制.
- 在临床前结直肠癌模型中评估7A的疗效.
主要方法:
- 进行了体内和体外实验.
- 关键的技术包括RNA测序,西式涂抹和聚合酶链反应 (PCR).
主要成果:
- 7A诱导了结直肠癌细胞中的显著DNA损伤.
- 观察到P53通路的激活和随后的亡.
- 7A治疗导致血管生成减少和瘤重量减少.
结论:
- 涅拉提尼布衍生物7A有效地促进结直肠癌细胞的亡.
- 7A 具有抗血管性质,并抑制瘤生长.
- 7A代表了结直肠癌治疗的有前途的治疗候选者.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
相关概念视频
The Intrinsic Apoptotic Pathway
Targeted Cancer Therapies
There are several types of targeted therapies against...
Inhibition of Cdk Activity
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
